Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Analgesia for Postoperative Pain after Sacrospinous Ligament Fixation
NCT03995641Phase 4Withdrawn
- Sponsor
- Kettering Health
- Start
- Feb 2019
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, triamcinolone in postoperative pain, sponsored by Kettering Health. Planned start Feb 2019; status: withdrawn.
02
Drugs
bupivacainetriamcinolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03995641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03995641.